Actinium Pharmaceuticals Company Profile (NYSEMKT:ATNM)

About Actinium Pharmaceuticals

Actinium Pharmaceuticals logoActinium Pharmaceuticals, Inc. (Actinium) is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its alpha particle immunotherapy platform and other related technologies. The Company's products include Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), and Iomab-B, an antibody-drug construct containing iodine 131 (I-131). Actimab-A is in human clinical trials stage for acute myeloid leukemia (AML) and Iomab-B in clinical trial stage for use in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. Its products under development are monoclonal antibodies labeled with radioisotopes. It has four product candidates in clinical trials: Actimab-A (HuM195-Ac-225), Iomab-B (BC8-I-131), BC8-Y-90 and BC8-SA. It is pursuing development of Actimab-A and Iomab-B, while BC8-Y-90 and BC8-SA are in physician sponsored clinical phase I trials.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: ATNM
  • CUSIP:
Key Metrics:
  • Previous Close: $1.43
  • 50 Day Moving Average: $1.06
  • 200 Day Moving Average: $1.28
  • 52-Week Range: $55,747,000.00 - $0.86
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.26
  • P/E Growth: 0.00
  • Market Cap: $83.06M
  • Outstanding Shares: 55,747,000
Additional Links:

Analyst Ratings

Consensus Ratings for Actinium Pharmaceuticals (NYSEMKT:ATNM) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Actinium Pharmaceuticals (NYSEMKT:ATNM)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Actinium Pharmaceuticals (NYSEMKT:ATNM)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Actinium Pharmaceuticals (NYSEMKT:ATNM)
Current Year EPS Consensus Estimate: $-0.48 EPS
Next Year EPS Consensus Estimate: $-0.35 EPS

Dividends

Dividend History for Actinium Pharmaceuticals (NYSEMKT:ATNM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Actinium Pharmaceuticals (NYSEMKT:ATNM)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Actinium Pharmaceuticals (NYSEMKT:ATNM)
DateHeadline
finance.yahoo.com logoActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant Organizations (NYSEMKT:ATNM)
finance.yahoo.com - February 14 at 4:24 PM
finance.yahoo.com logoActinium Pharmaceuticals’ Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple Myeloma (NYSEMKT:ATNM)
finance.yahoo.com - February 13 at 4:12 PM
finance.yahoo.com logoActinium Pharmaceuticals (ATNM) has Considerable Potential in 2017 (NYSEMKT:ATNM)
finance.yahoo.com - February 10 at 4:11 PM
finance.yahoo.com logoActinium Pharmaceuticals to Present at BIO CEO & Investor Conference (NYSEMKT:ATNM)
finance.yahoo.com - February 9 at 3:50 PM
us.rd.yahoo.com logoActinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma (NYSEMKT:ATNM)
us.rd.yahoo.com - February 7 at 4:36 PM
us.rd.yahoo.com logo8:05 am Actinum Pharma initiates a Phase 1 clinical trial studying Actimab-M in multiple myeloma (NYSEMKT:ATNM)
us.rd.yahoo.com - February 7 at 4:36 PM
4-traders.com logoActinium Pharmaceuticals : The Biotech Market Grows as Demand for New Therapeutics Increases (NYSEMKT:ATNM)
www.4-traders.com - February 6 at 3:44 PM
finance.yahoo.com logoActinium’s Chief Medical Officer, Dr. Mark Berger, to Present Talk Titled, Iomab-B: Radiolabeled CD45 at the 3rd Annual Expert Forum on Acute Leukemias and Myeloproliferative Neoplasms (NYSEMKT:ATNM)
finance.yahoo.com - January 24 at 4:07 PM
News IconActinium Pharmaceuticals Inc ATNM Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSEMKT:ATNM)
www.bioportfolio.com - January 20 at 4:43 PM
finance.yahoo.com logoActinium Announces Participation in Three Upcoming Hematology Events (NYSEMKT:ATNM)
finance.yahoo.com - January 20 at 4:43 PM
finance.yahoo.com logoActinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer (NYSEMKT:ATNM)
finance.yahoo.com - January 18 at 4:19 PM
us.rd.yahoo.com logoActinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference (NYSEMKT:ATNM)
us.rd.yahoo.com - January 4 at 3:49 PM
globenewswire.com logoActinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference - GlobeNewswire (press release) (NYSEMKT:ATNM)
globenewswire.com - November 21 at 8:28 AM
finance.yahoo.com logoActinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference (NYSEMKT:ATNM)
finance.yahoo.com - November 21 at 8:28 AM
News IconMA Levels in Review for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 19 at 8:44 PM
News IconPenny Stock Focus: Narrowing the Lens On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 18 at 8:13 PM
News IconTrading Spotlight on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 17 at 9:00 PM
News IconPenny Stock Making Waves: Taking a Second Look at Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 17 at 9:00 PM
News IconUpdate on Valuation Formula's For Actinium Pharmaceuticals, Inc. (AMEX:ATNM) - Wall Street Lion (NYSEMKT:ATNM)
wslnews.com - November 16 at 9:31 PM
News IconAverage Directional Index in Review for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 16 at 9:31 PM
News IconTraders are Following Technical Levels for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 15 at 3:46 PM
News IconPenny Stock Making News: Putting the Microscope On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 15 at 3:46 PM
News IconThe Next Wonder Penny Stock? Investors Keen On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 15 at 3:46 PM
News IconNarrowing in on Chart Levels for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 14 at 3:51 PM
News IconChecking on CCI, MA, RSI and ADX for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 11 at 8:23 PM
News IconPenny Stock News: Looking Closer At Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 11 at 8:23 PM
News IconSignal Watch: Checking the Numbers for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 10 at 9:47 PM
News IconPenny Stock Interest: Checking In On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 10 at 9:47 PM
News IconActinium Pharmaceuticals, Inc. (ATNM) Updated Analyst Coverage - NewsDen (NYSEMKT:ATNM)
newsden.net - November 10 at 2:10 PM
News IconRoth Capital initiates coverage on Actinium Pharma (Nasdaq: ATNM) - StockNewsUnion (NYSEMKT:ATNM)
stocknewsunion.com - November 10 at 2:10 PM
News IconStock Checkup: Technical Watch on Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 9 at 10:16 PM
News IconMeasuring the Levels on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 9 at 12:33 PM
News IconPenny Stock Update: Traders Looking Closely at Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 9 at 12:33 PM
News IconNewsworthy Penny Stock: Zeroing In On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 8 at 2:21 PM
News IconVC Score In Focus for Actinium Pharmaceuticals, Inc. (AMEX:ATNM) - StockTalk Daily (NYSEMKT:ATNM)
stocktalkdaily.com - November 7 at 1:34 PM
News IconTechnical Focus: What's Happening With Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 7 at 1:34 PM
News IconShares Knocked Down Over Past Month: Actinium Pharmaceuticals, Inc. (:ATNM) - CSZ News (NYSEMKT:ATNM)
cincysportszone.com - November 6 at 8:26 AM
News IconCCI Focus on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 5 at 11:35 AM
News IconPenny Stock Update: Looking At Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 5 at 11:35 AM
News IconTrading Scope: Following Levels on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 2 at 4:00 PM
News IconTechnical Investor Update on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - November 1 at 3:40 PM
News IconNewsworthy Penny Stock: Investors Checking In On Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - November 1 at 3:40 PM
News IconActinium Pharmaceuticals, Inc.'s (ATNM): Stock on the Move | Hot ... - Hot Stocks Point (NYSEMKT:ATNM)
www.hotstockspoint.com - October 31 at 3:40 PM
News Icon#Pharma News: Actinium Pharmaceuticals (NYSE: ATNM) Announces Key Hire in Clinical Supply Chain Organization ... - InvestorIdeas.com (press release) (NYSEMKT:ATNM)
www.investorideas.com - October 31 at 3:40 PM
finance.yahoo.com logoActinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain Organization as Company Expands To Accommodate Continued Growth (NYSEMKT:ATNM)
finance.yahoo.com - October 31 at 9:39 AM
News IconPenny Stock News: Checking in on Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - October 29 at 3:38 PM
News IconTracking Williams %R for Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - October 28 at 1:19 PM
News IconWatching Technical Levels on Shares of Actinium Pharmaceuticals Inc. (ATNM) - MicroCap Wired (NYSEMKT:ATNM)
www.microcapwired.com - October 27 at 3:52 PM
News IconInvestor's Alert: Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), Enphase Energy, Inc. (NASDAQ:ENPH) - The Newburgh Press (NYSEMKT:ATNM)
newburghpress.com - October 27 at 3:52 PM
News IconMaking News: Update on Penny Stock Actinium Pharmaceuticals, Inc. (:ATNM) - Duncan Research (NYSEMKT:ATNM)
www.duncanindependent.com - October 26 at 3:41 PM

Social

What is Actinium Pharmaceuticals' stock symbol?

Actinium Pharmaceuticals trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "ATNM."

How do I buy Actinium Pharmaceuticals stock?

Shares of Actinium Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Actinium Pharmaceuticals stock cost?

One share of Actinium Pharmaceuticals stock can currently be purchased for approximately $1.49.


Last Updated on 2/19/2017 by MarketBeat.com Staff